3.00
Kyverna Therapeutics Inc Aktie (KYTX) Neueste Nachrichten
KYTX Deadline: KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PR Newswire
Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025KYTX - PR Newswire
The Gross Law Firm Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025KYTX - PR Newswire
Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX - GlobeNewswire Inc.
KYTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors - The Bakersfield Californian
Deadline Soon: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Kyverna Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesKYTX - PR Newswire
Class Action Filed Against Kyverna Therapeutics, Inc. - GlobeNewswire
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm - PR Newswire
KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Final Deadline for the Kyverna Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsKYTX - PR Newswire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) - openPR
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
KYVERNA THERAPEUTICS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc.KYTX - Business Wire
KYTX FINAL DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire
DEADLINE ALERT for BOOM, KYTX, MQ, and SUI: The Law Offices - GlobeNewswire
KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
2025-02-03 | KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Kyverna Therapeutics, Inc. to Contact the Firm Today! | NDAQ:KYTX | Press Release - Stockhouse Publishing
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Short Interest Up 13.9% in January - MarketBeat
The Gross Law Firm Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineKYTX - PR Newswire
Shareholders that lost money on Kyverna Therapeutics, - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - GlobeNewswire
2025-02-02 | KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:KYTX | Press Release - Stockhouse Publishing
KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ky - PR Newswire
KYTX DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire
KYTX Shareholder Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PR Newswire
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Deadline Alert: Kyverna Therapeutics, Inc. (KYTX) Investors - GlobeNewswire
Deadline Alert: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact Glancy Prongay & - EIN News
Kyverna Therapeutics, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before February 7, 2025 to Discuss Your RightsKYTX - PR Newswire
KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian
KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - GlobeNewswire Inc.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure ... - The Hastings Tribune
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna - GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - The Eastern Progress Online
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - Victoria Advocate
Kyverna Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Morningstar
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadli - GuruFocus.com
Kyverna Therapeutics Class Action: How to File a Claim Against the Firm - Lawyer Monthly Magazine
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. LawsuitKYTX - PR Newswire
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit - The Malaysian Reserve
Kessler Topaz Meltzer & Check, LLP Announces KYTX DEADLINE REMINDER: Important February 7, 2025 Deadline Reminder in Kyverna Therapeutics, Inc. Securities Class Action Lawsuit - Business Wire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):